Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.22.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2021
Dec. 31, 2020
Current assets:    
Cash, cash equivalents and restricted cash $ 231,900 $ 272,350
Total short term investments 234,178 125,979
Accounts receivable, net 15,414 0
Inventories, net 19,326 13,927
Prepaid expenses and other current assets 12,506 7,171
Total current assets 513,324 419,427
Non-current assets:    
Long-term investments 0 24,380
Other non-current assets 11,838 247
Property and equipment, net 4,418 4,786
Acquired intellectual property and other intangible assets, net 8,404 9,332
Right-of-use assets 5,383 5,489
Total assets 543,367 463,661
Current liabilities:    
Accounts payable and accrued liabilities 34,947 24,797
Other current liabilities (of which $6,000 due to related party in 2020) 4,640 6,412
Operating lease liabilities 1,059 788
Total current liabilities 40,646 31,997
Non-current liabilities:    
Deferred compensation and other non-current liabilities 15,950 16,295
Operating lease liabilities 7,680 7,619
Liabilities 64,276 55,911
Commitments and Contingencies
Stockholders' equity    
Common shares - no par value, unlimited shares authorized, 141,600 and 126,725 shares issued and outstanding at December 31, 2021 and 2020, respectively 1,177,051 944,328
Additional paid-in capital 59,014 39,383
Accumulated other comprehensive loss (852) (805)
Accumulated deficit (756,122) (575,156)
Total shareholders' equity 479,091 407,750
Total liabilities and shareholders' equity $ 543,367 $ 463,661